Interparfums (NASDAQ:IPAR) versus BioHarvest Sciences (NASDAQ:BHST) Head to Head Review

BioHarvest Sciences (NASDAQ:BHST) and Interparfums (NASDAQ:IPAR) are both consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Institutional & Insider Ownership

55.6% of Interparfums shares are owned by institutional investors. 43.6% of Interparfums shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares BioHarvest Sciences and Interparfums”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioHarvest Sciences	$34.51 million	0.89	-$11.14 million	($0.52)	-3.02
Interparfums	$1.49 billion	2.58	$168.39 million	$5.23	22.92

Interparfums has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Interparfums, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

BioHarvest Sciences has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. Comparatively, Interparfums has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500.

Profitability

This table compares BioHarvest Sciences and Interparfums’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioHarvest Sciences	-31.21%	-58.30%	-25.60%
Interparfums	11.17%	15.21%	10.85%

Analyst Ratings

This is a summary of current recommendations for BioHarvest Sciences and Interparfums, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioHarvest Sciences	1	0	2	0	2.33
Interparfums	1	5	2	0	2.12

BioHarvest Sciences presently has a consensus target price of $6.50, suggesting a potential upside of 314.01%. Interparfums has a consensus target price of $123.29, suggesting a potential upside of 2.86%. Given BioHarvest Sciences’ stronger consensus rating and higher possible upside, research analysts plainly believe BioHarvest Sciences is more favorable than Interparfums.

Summary

Interparfums beats BioHarvest Sciences on 11 of the 13 factors compared between the two stocks.

About BioHarvest Sciences

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.

About Interparfums

Inter Parfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. It operates in two segments, European Based Operations and United States Based Operations. The company offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Emanual Ungaro, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta, Ungaro, and Roberto Cavalli brands, as well as French Connection, Intimate, and Dunhill, Lacoste names. It sells its products to department stores, perfumeries, specialty stores, duty free shops, and domestic and international wholesalers, and distributors, as well as through e-commerce. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Inter Parfums, Inc. was founded in 1982 and is headquartered in New York, New York.